ReviewAmerican journal of public health2008
Corporate philanthropy, lobbying, and public health policy.
Review in American journal of public health, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
41 citing papers in PubMed.
- Article
- Aiding empirical research on the commercial determinants of health: a scoping review of datasets and methods about lobbying.Health research policy and systems · 2023Article
- Quantitative revenue estimates and qualitative assessments of innovative fundraising sources for treating rare diseases in Colombia.Journal of market access & health policy · 2023Article
- National Public Health Surveillance of Corporations in Key Unhealthy Commodity Industries - A Scoping Review and Framework Synthesis.International journal of health policy and management · 2023Article
- European-wide policymaking at the urban level: a qualitative study.European journal of public health · 2021Article
- The Pandemic That Always Strains Critical Care: Smoking.Annals of the American Thoracic Society · 2021Article
- Developing more detailed taxonomies of tobacco industry political activity in low-income and middle-income countries: qualitative evidence from eight countries.BMJ global health · 2021Article
- 'Pro-tobacco propaganda': a case study of tobacco industry-sponsored elementary schools in China.Tobacco control · 2020Article
- Cigarette Packs With URLs Leading to Tobacco Company Websites: Content Analysis.Journal of medical Internet research · 2020Article
- The environmental externalities of tobacco manufacturing: A review of tobacco industry reporting.Ambio · 2020Review
- Limited-edition smokeless tobacco packaging: Behind the camouflage.Tobacco induced diseases · 2019Article
- United Nations Global Compact: an 'Inroad' into the UN and reputation boost for the tobacco industry.Tobacco control · 2018Article
- "An example for corporate social responsibility": British American Tobacco's response to criticism of its Myanmar subsidiary, 1999-2003.Asia & the Pacific policy studies · 2018Article
- African media coverage of tobacco industry corporate social responsibility initiatives.Global public health · 2018Article
- US Media Coverage of Tobacco Industry Corporate Social Responsibility Initiatives.Journal of community health · 2018Article
- Article
- Controlling corporate influence in health policy making? An assessment of the implementation of article 5.3 of the World Health Organization framework convention on tobacco control.Globalization and health · 2017Article
- Development of the FDA Tobacco Credibility Scale (FDA-TCS).Tobacco regulatory science · 2017Article
- Shared vision, shared vulnerability: A content analysis of corporate social responsibility information on tobacco industry websites.Preventive medicine · 2016Article
- "What Is Our Story?" Philip Morris's Changing Corporate Narrative.American journal of public health · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
To counter negative publicity about the tobacco industry, Philip Morris has widely publicized its philanthropy initiatives. Although corporate philanthropy is primarily a public relations tool, contributions may be viewed as offsetting the harms caused by corporate products and practices. That such donations themselves have harmful consequences has been little considered. Drawing on internal company documents, we explored the philanthropy undertaken as part of Philip Morris's PM21 image makeover. Philip Morris explicitly linked philanthropy to government affairs and used contributions as a lobbying tool against public health policies. Through advertising, covertly solicited media coverage, and contributions to legislators' pet causes, Philip Morris improved its image among key voter constituencies, influenced public officials, and divided the public health field as grantees were converted to stakeholders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.